Literature DB >> 2443361

Interferons in oncology: current status and future directions.

J F Smyth1, F R Balkwill, F Cavalli, A Kimchi, K Mattson, N E Niederle, R J Spiegel.   

Abstract

The European School of Oncology has formed a study group to consider the present status of interferons in oncology. This position paper summarizes the discussions and conclusions of the first meeting of this study group.

Mesh:

Substances:

Year:  1987        PMID: 2443361     DOI: 10.1016/0277-5379(87)90298-7

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN: 0277-5379


  1 in total

1.  Characterisation and properties of a small cell lung cancer cell line and xenograft WX322 with marked sensitivity to alpha-interferon.

Authors:  S P Langdon; G J Rabiasz; L Anderson; A A Ritchie; R J Fergusson; F G Hay; E P Miller; P Mullen; J Plumb; W R Miller
Journal:  Br J Cancer       Date:  1991-06       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.